Patients who maintained venetoclax concentrations above 2605 ng/mL were more likely to stay in remission, while those exceeding 4060 ng/mL faced a higher risk of toxicity.
Acute myeloid leukemia (AML) poses an increasing global burden for older adults, according to a study published online Aug.
Stocktwits on MSN
SLS stock charges ahead as AML trial buzz builds: Report claims Regal hit 80th event — retail isn’t convinced
The company’s latest official count remains 78 events, with final AML data expected after the required review process.
Kura Oncology (NASDAQ:KURA) drew attention as its oral menin inhibitor gained traction in AML, keeping the biotech in focus ...
Medications for AML include chemotherapy and newer targeted therapies. With several options available, the right medication for you will depend on the specific characteristics of your cancer. Acute ...
Asianet Newsable on MSN
SLS traders eye this important resistance zone ahead of key AML data readout
Sellas shares reached a swing high of $15.88 in late June before tumbling 42% to a July low of $9.19.
Researchers evaluated a low-dose chemotherapy induction regimen compared with standard-dose therapy in pediatric patients with AML.
Stergiou highlighted a Phase 2 study published in the Blood Advances journal that evaluated a maintenance therapy in 17 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results